Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
18.00    -0.50 (-2.70%)
Bid:
17.00
Ask:
19.00
Spread: 2.00 (11.765%)
Market Cap: £16.31m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Growth Share Scheme

18 Feb 2026 07:00

RNS Number : 4037T
Mission Group PLC (The)
18 February 2026
 

18 February 2026

The Mission Group plc

("MISSION" the "Company" or the "Group")

Growth Share Scheme

The MISSION Group plc (AIM: TMG), creator of Work That CountsTM, comprising a group of digital marketing and communications Agencies, is pleased to announce the formation of a new senior management retention and incentive scheme.

The Growth Share Scheme Arrangement (the "Scheme") reflects the Board's commitment to aligning the long-term interests of our people with those of shareholders. Attracting, retaining and motivating high-calibre talent is critical to delivering our strategic objectives and creating sustainable shareholder value. The Scheme is designed to incentivise strong performance, reward long-term contribution and foster a culture of ownership across the Group. By linking reward to the Company's success, the Board believes the Scheme will support continued growth and enhance value creation for all stakeholders. The Scheme only has value to the participants if the share price of the Company increases substantially.

The Scheme

Under the Scheme, selected individuals are invited to subscribe for B ordinary shares in The Mission Marketing Holdings Limited ("B Shares"). These B Shares are subscribed for at a nominal value of 0.01p per B Share and will only have a material value if at any time in the period ending on the date the Company's financial results for the year ended 31st December 2028 are announced, or prior to a change of control or voluntary liquidation of the Company if sooner, the closing market value of the Company equals or exceeds 35p per share for fifteen consecutive days when the AIM market is open for business ("Vesting Condition").

If the Vesting Condition is met, those individuals who still hold B Shares at the relevant time will be entitled to require the Company to acquire their B Shares. The Company, in its absolute discretion, can determine to pay for the B Shares in cash (calculated on the basis of a price per B Share equal to the market value of an Ordinary Share at that time) , in Ordinary Shares of 10p each in the capital of the Company ("Ordinary Shares") (calculated on the basis of one Ordinary Share for each B Share) or in a combination of Ordinary Shares and cash. The Ordinary Shares issued following the acquisition of B Shares are not subject to any form of lock up or orderly market agreement or minimum holding period including post-employment holding. The B Shares are not entitled to any dividends paid by the Company in the period prior to the date that Ordinary Shares are issued following the acquisition of B Shares by the Company. There are no malus or clawback provisions following the acquisition of B Shares by the Company.

The B Shares are also subject to drag along and tag along rights which provide that, if the Company wishes to dispose of some or all of its shares in The Mission Marketing Holdings Limited then in certain circumstances the holders of the B Shares can either be required to sell, or can require the person acquiring such shares to buy, their B Shares and in either case the price to be paid to the holders of the B Shares depends on whether the Vesting Condition has been met at the time of such disposal and, if it has, the price is calculated by reference to the market value of an Ordinary Share at that time as it would on a change of control, voluntary liquidation of the Company or following the date the Company's financial results for the year ended 31st December 2028 are announced.

The B Shares have no value if the Vesting Condition is not met. If any holder of B Shares ceases to be employed by a member of the Company's group (otherwise than by reason of death, permanent illness or incapacity, redundancy or other reason determined by the Company) then, unless the board of The Mission Marketing Holdings Limited (with the written consent of the Company's Remco)determines otherwise (in which case the holder of the B Share retains those B Shares), they shall be required to sell their B Shares to the Company for £1 in aggregate. The Company has the discretion to rebase or adjust the Vesting Condition to take into account objective changes in circumstances that occur after the B Shares are issued but prior to the date that Ordinary Shares are issued following the acquisition of B Shares by the Company. This discretion does not apply in the event of an early Vesting Condition following a change of control or voluntary liquidation of the Company.

To achieve the Vesting Condition, the share price of the Company will need to increase by a minimum of 86.7% from its current level of 18.75 pence to achieve a 35p share price, which would represent an increase in market capitalisation of approximately £15m. Under the Scheme, the B Shares would have an aggregate value at the 35p level of approximately £3.5m and could be exchanged for a maximum of 10,000,000 Ordinary Shares. The total potential number of Ordinary Shares that could be issued under the Scheme and under other existing option schemes is 10,234,192, representing 11.1% of the issued share capital.

In total, 10,000,000 B Shares were subscribed for on 17 February 2026 (the "Award") by a limited number of board members and non-PDMR senior managers. The subscription details for board members of MISSION are detailed below.

 

Name

Position

Number of B Shares

David Morgan

Non-Executive Chair

1,450,000

John Carey

Group Chief Executive

1,500,000

Giles Lee

Chief Financial Officer

1,450,000

Other senior management

5,600,000

Total

 

10,000,000

 

 

* The Vesting Condition requires the closing market value of the Company to equal or exceed 35p per Ordinary Share for fifteen consecutive days when the AIM market is open for business at any time prior to the date on which the Company's financial results for the year ended 31st December 2028 are announced.

ENDS

ENQUIRIES

John Carey, Chief Executive Officer

Giles Lee, Chief Financial Officer

Via Houston

 

The MISSION Group PLC

Simon Bridges / Andrew Potts / Harry Rees

Canaccord Genuity Limited

(Financial Adviser, Nominated Adviser and Broker)

020 7523 8000

Peter Tracey

Blackdown Partners Limited

(Financial Adviser)

020 3807 8484

Kate Hoare / Charlie Barker

077 33 032 695 / 020 4529 0549 

E: mission@houston.co.uk

Houston PR

 

NOTES TO EDITORS 

The MISSION Group Plc. is the Alternative Group for Ambitious Brands. 

Delivering measurable, results-driven campaigns as the preferred creative partner for real business growth. We offer top-tier agencies, strategic specialisms and global reach delivering outstanding performance for brands. We call it Work That Counts™ www.themission.co.uk

 

a)

 

Name

 

 

David Morgan

John Carey

Giles Lee

 

2

 

Reason for the notification

a)

 

Position/status

 

 

David Morgan

 Non-Executive Chair

John Carey

 Group Chief Executive

Giles Lee

 Chief Financial Officer

 

b)

 

Initial notification /Amendment

 

18 February 2026

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

The Mission Group plc

b)

 

LEI

213800L567CF3Z6GPZ03

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

B ordinary shares in The Mission Marketing Holdings Limited, exchangeable into ordinary shares of 10p each the capital of the Company upon the satisfaction of performance criteria 

 

GB00B11FD453

b)

 

Nature of the transaction

Award of Growth Shares  

c)

 

Price(s) and volume(s)

 

 

Price

Volume

David Morgan

0.01p

1,450,000

John Carey

0.01p

1,500,000

Giles Lee

0.01p

1,450,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 4,400,000

 

0.01p

e)

 

Date of the transaction

17 February 2026

f)

 

Place of the transaction

Off Market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZGMZLNLGVZM
Date   Source Headline
24th Sep 20217:30 amRNSHolding(s) in Company
23rd Sep 20216:10 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSInterim Results for six months to 30 June 2021
14th Jul 20217:00 amRNSTRADING UPDATE AND NOTICE OF INTERIM RESULTS
28th Jun 20217:00 amRNSGrowth Share Scheme
25th Jun 20212:17 pmRNSHolding(s) in Company
15th Jun 20217:00 amRNSDirector/PDMR Shareholding
14th Jun 20211:38 pmRNSResult of AGM
14th Jun 20217:00 amRNSTR1: Notification of Major Holdings
11th May 20219:19 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSDirectorate Changes
26th Apr 20215:05 pmRNSCorrection: Director/PDMR Shareholding
26th Apr 202112:15 pmRNSDirector/PDMR Shareholding
19th Apr 20216:04 pmRNSDirector/PDMR Shareholding
14th Apr 20217:01 amRNSFinal Results for the Year Ended 31 December 2020
14th Apr 20217:00 amRNSChanges to the Board
11th Mar 20214:40 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSHolding(s) in Company
22nd Feb 20215:37 pmRNSDirector/PDMR Shareholding
9th Feb 20219:24 amRNSDirector/PDMR Shareholding
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSTrading Update and Notice of Results
11th Nov 20204:58 pmRNSHolding(s) in Company
23rd Sep 20207:00 amRNSInterim Results
27th Jul 20207:00 amRNSACQUISITION OF INNOVATIONBUBBLE
15th Jul 20207:00 amRNSTrading Statement and Notice of Interim Results
15th Jun 20203:37 pmRNSResult of AGM
21st May 20207:00 amRNSCovid-19 and AGM Update
11th May 20204:58 pmRNSDirector Dealing and Issue of Consideration Shares
17th Apr 20203:36 pmRNSIssue of Equity
7th Apr 20205:00 pmRNSPDMR Shareholding pursuant to Growth Share Scheme
1st Apr 20207:00 amRNSFinal Results for the year ended 31 December 2019
27th Mar 20205:22 pmRNSCOVID-19 UPDATE
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
13th Mar 20202:22 pmRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Update
9th Dec 201911:55 amRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSLaunch of Global Competition
25th Sep 20197:00 amRNSChange of Name
25th Sep 20197:00 amRNSHalf-year Report
13th Aug 20197:00 amRNSEBT Share Dealings
7th Aug 20198:15 amRNSEBT Share Dealings
1st Aug 20191:11 pmRNSDirector/PDMR Shareholding - Replacement
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
15th Jul 20197:00 amRNSTrading Update
17th Jun 201912:57 pmRNSResult of AGM
17th Jun 201911:58 amRNSBoard Changes
12th Jun 20195:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.